A Phase III International Multi-center, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition with Tilarginine Acetate Injection in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction,

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2005
This article has no abstract
Epistemonikos ID: 3a20da5e4a6a57e693bae44e4aee76a420f88230
First added on: Jan 21, 2025